TechCrunch – September 2023

At Stimvia, we believe that everyone deserves access to safe and effective medical treatments.
We’re committed to developing our neuromodulation technology to the highest standards…

PDF article: …. link HERE

CzechCrunch magazine – July 2023

At Stimvia, we believe that everyone deserves access to safe and effective medical treatments.
We’re committed to developing our neuromodulation technology to the highest standards…

The Journal of Urology – April 2023

Our recent study, led by Jan Krhut and featuring team members Michal Rejchrt, Martin Slovak, Roman V. Dvorak, Lukas Peter, Bertil FM Blok and Peter Zvara, compared the effectiveness of the URIS neuromodulation system and Solifenacin for treating overactive bladder (OAB) has been published in the prestigious journal The Journal of Urology.

Sustainability – EN ISO 14001:2025 – March 2023

Our URIS® device improves the quality of life of incontinence patients while protecting the environment! Stimvia has successfully passed a sustainability audit regarding its production processes and the company. This audit earned us certification according to the European standard EN ISO 14001:2025, which confirms our commitment to environmental responsibility.

Delloite Fast 50 CE – December 2022

Awards for products with a revolutionary impact on the market, Stimvia was awarded as IMPACT STARS

Věda a výzkum – November 2022

Czech company comes with unique technology for the treatment of chronic disease. …

Czech Industry magazine- 2022

Česká společnost Stimvia vyvinula průlomovou technologii na léčbu nemocí spojených s centrální nervovou soustavou. …

Victory in the 4DigitalHealth accelerator – January 2021

The winner of the 4DigitalHealth accelerator is the Czech startup Tesla Medical. …

Click here for opt-out of Google analytics